Skip to main content

CalciMedica, Inc.

CALC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001534133

No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding CalciMedica, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of CALC: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders2827−1
Shares11.3M11.0M−328.2K (−2.9%)
Value$20.7M$13.5M−$7.20M (−34.8%)

New holders (4)

Institutions that held CalciMedica, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to CALC in Q1 2022
InstitutionSharesValue% of portfolio
Bank of New York Mellon Corp101,646$125.0K0.00%
JPMorgan Chase & Co538$1.00K0.00%
Citigroup Inc30$00.00%
Advisor Group Holdings, Inc.19,000––

Sold out (5)

Institutions that held CalciMedica, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of CALC in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Sculptor Capital LP130,900$240.0K
Gsa Capital Partners LLP86,199$158.0K
Two Sigma Advisers, LP26,000$48.0K
Simplex Trading, LLC9,459$17.0K
Bank of America Corp111$0